On 14 September, mark your calendars for a must-attend event at BIO2023 Congress in Szczecin, Poland.
PolTREG’s CEO Prof. Piotr Trzonkowski, who also represents The Department of Clinical Immunology and Transplantology, Medical University of Gdansk, will be taking the stage to present a captivating lecture: “The Phenotype of T Regulatory Cells as a Predictor of the Efficacy of Treg Therapy.”
Why should you see this presentation?
Prof. Piotr Trzonkowski is a renowned expert in the field of TREG-based cell therapies, with an impressive 17-year experience in developing groundbreaking TREG therapies. With his practical knowledge and experience, this presentation promises to be enlightening and insightful.
Stay tuned for more details on this presentation, and make sure to save the date! This is an opportunity you won’t want to miss if you are passionate about the future of healthcare and TREG therapies.
